Home
About
News
Resources
Events
FAQ & Support
Programs
Laws and Regulations Governing Buprenorphine for OUD
Managing the Legal Risks of Prescribing Controlled Medications
Preparing for and Responding to DEA Visits
Prescribing Buprenorphine for OUD During a Public Health Emergency
Home
About
News
Resources
Events
FAQ & Support
Programs
Laws and Regulations Governing Buprenorphine for OUD
Managing the Legal Risks of Prescribing Controlled Medications
Preparing for and Responding to DEA Visits
Prescribing Buprenorphine for OUD During a Public Health Emergency
All Posts By
admin
FDA Recommends Discussing Naloxone When Prescribing Opioids
News
July 23, 2020
Drug Overdose Deaths Up 4.6% in 2019
News
July 16, 2020
DOJ Targets Pain Management Specialists
News
July 4, 2020
Pandemic Unleashes a Spike in Overdoses, Deaths
News
June 29, 2020
PAINWeek 2020
June 11, 2020
2020 Pain Care Legislation and Public Policy Webinar
June 10, 2020
Rx Summit 2020
April 14, 2020
COVID-19: OUD Practice and Policy Considerations
News
April 3, 2020
Preparing for and Responding to DEA Visits
March 25, 2020
Prescribing Buprenorphine via Telemedicine During a Public Health Emergency
March 18, 2020
Managing the Legal Risks of Prescribing Controlled Medications
March 11, 2020
Laws and Regulations Governing Buprenorphine Treatment
March 4, 2020
More
« Previous
